Using its deep expertise in payment systems in Europe, MTRC has started provision of service of cost analysis to inform the development of health economic models and adaptation of existing models to settings of 19 European countries.

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.